By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Potential Malaria Detection, Drug Sensitivity Handheld Testing Device on Indiegogo
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Global Healthcare > Potential Malaria Detection, Drug Sensitivity Handheld Testing Device on Indiegogo
BusinessDiagnosticsGlobal HealthcareMedical DevicesTechnology

Potential Malaria Detection, Drug Sensitivity Handheld Testing Device on Indiegogo

Deanna Pogorelc
Deanna Pogorelc
Share
4 Min Read
SHARE

QuantuMDxFirst published on MedCityNews.com. A “handheld laboratory” designed to diagnose malaria in under 15 minutes could be in the hands of healthcare workers overseas within two years if QuantuMDx can meet the ambitious goals it’s set for itself.

QuantuMDxFirst published on MedCityNews.com. A “handheld laboratory” designed to diagnose malaria in under 15 minutes could be in the hands of healthcare workers overseas within two years if QuantuMDx can meet the ambitious goals it’s set for itself.

The medical device company has turned to Indiegogo in search of $50,000 for field trials of its miniaturized DNA sequencing device.

Unlike many other crowdfunding campaigns, this is no early-stage project. Molecular geneticist Jonathan O’Halloran has been working on it for years. The company comprises 35 people in three countries, and CEO Elaine Warburton said it’s raised $22 million in grants and angel money.

More Read

Botiful Android Robot You Use and Control With Skype Video Conferencing–Start Up Company At KickStarter–We Need This Robot for All Video Conferencing
Regulation of Wound Management Products
Hospital Marketing Opportunity Revealed: Get a YouTube Channel, Get Ahead.
Majority of Seniors Want Digital Tools to Manage Their Health
Shorter Wait in the ER Just a Click Away with Startup’s Virtual Waiting Service

In an effort to “fight off venture capital” and keep its efforts humanitarian-focused, Warburton said crowdfunding seemed like a smart strategy. Donors will be directly contributing to the development and testing of the device by “purchasing” cartridges for trials and suggesting names for the device.

O’Halloran’s idea was to shrink a diagnostic laboratory into a small device that could conduct DNA analysis without electricity or water and could be carried into the field, to avoid the waiting period that comes with sending samples to a molecular diagnostics laboratory.

“We had to reinvent many of the processes, all the way from sample prep to amplification,” he explained.

The first application of the device will focus on malaria, an infectious disease that kills more than 620,000 people a year – most commonly children in sub-Saharan Africa, according to the WHO. One of the big problems with malaria is that it’s mutated over the years and now in some cases is resistant to the most common antibiotic treatment regimen.

QuantuMDx is working with researchers at St. George’s and University of London to develop assays not only for diagnosis but for drug susceptibility testing, so that a field worker could provide an infected person with the best treatment on the spot.

A finger-prick blood sample is placed on one of QuantuMDx’s disease-specific cartridges that contain all of the reagents and sensors required to process the sample. The cartridge is placed in the device and within 15 minutes results appear on the touch screen, telling the healthcare worker whether malaria was detected in the sample, what species it is and whether it showed traits of drug resistance.

The company has a working prototype it’s used to run diagnostic tests and plans to begin field trials in Africa mid-year. The plan is to compare results the device generates with the gold standard molecular test for malaria. If the results are good, Warburton said the company plans to commercialize first in Africa and India, then other developing nations and eventually Europe and the U.S.

As of Wednesday morning, the campaign had raised about $2,500.

[Image credit: QuantuMDx]

TAGGED:malaria
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025
Choosing the Right Swimwear for Health and Safety
News
September 30, 2025
sports concussions
Concussion In Sports: How Common They Are And What You Need To Know
Infographics
September 28, 2025

You Might also Like

A Theory on Why The FDA Hid Conflicts of Interest

January 15, 2012

Doc to Dock Sends Medical Supplies to Those in Need

March 28, 2011

MelaFind Gets FDA Approval For Detecting Melanoma

September 29, 2011

More Clinical Research Trials Moving to China

May 9, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?